Transforming mental healthcare from
art to science,
starting with PTSD.
We Target Biomarkers for a Precision Medicine Approach to Mental Health Disorders
Current mental healthcare tools are inadequate, leaving tens of millions of people suffering. PTSD healthcare is no exception, characterized by failures to understand and address its root cause.
Our approach is different. Pioneering research uncovered PTSD’s underlying mechanisms of action, and our comprehensive solution to both diagnosis and treatment centers on measurable, targetable brain biomarkers.
Latest News
-
Dr. Perusini featured in Project W "2023 Impact Report"
January 2024
-
Columbia Women's Business Society (The Scope): Dr. Jennifer Perusini of Neurovation Labs
February 28, 2023
-
The Women of New York Biotech: 2022 Year in Review
December 30, 2022
Events
-
CEO Jennifer Perusini Presenting at St Andrews Defence Tech & STATIC
April 8, 2024
CEO Jennifer Perusini to present as an invited speaker at an event hosted by St Andrews Defence Tech and STATIC.
-
CEO Jennifer Perusini to be Keynote Panelist at Incubator Spring Showcase
April 11, 2024
CEO Jennifer Perusini to be Keynote Panelist at Barnard College Athena Center for Leadership Incubator Spring Showcase.
-
CEO Jennifer Perusini to present at Barnard College’s 4th Annual Startup Summit
June 7, 2024
Hosted by Barnard College's Athena Center for Leadership and Barnard Entrepreneurs Network.